Ahmad Kaviani1, Amin Safavi2, Narjes Mohammadzadeh3, Khatereh Jamei4, Maryam Ansari-Damavandi4, Remy J Salmon5. 1. Department of Surgery, Tehran University of Medical Sciences (TUMS), P.O. Box 13145-158, Tehran, Iran; Department of Research, Kaviani Breast Diseases Institute (KBDI), P.O. Box 14358-6443, Tehran, Iran. Electronic address: akaviani@tums.ac.ir. 2. Department of Surgery, Tehran University of Medical Sciences (TUMS), P.O. Box 13145-158, Tehran, Iran; Department of Research, Kaviani Breast Diseases Institute (KBDI), P.O. Box 14358-6443, Tehran, Iran. 3. Department of Surgery, Tehran University of Medical Sciences (TUMS), P.O. Box 13145-158, Tehran, Iran. 4. Department of Research, Kaviani Breast Diseases Institute (KBDI), P.O. Box 14358-6443, Tehran, Iran. 5. Hôpital des Peupliers, 80 Rue de la Colonie, Paris 75013, France.
Abstract
BACKGROUND: The oncologic efficacy of breast-conserving therapies has been established in recent decades. Oncoplastic breast surgery (OBS), as a leap forward in breast conservation, offers concomitant techniques of oncologic and plastic surgeries that grant better esthetic results. The outcomes of our oncoplastic surgeries from 2007 to 2012 are reported. METHODS: A series of 258 cases with breast masses (18 benign and 240 carcinomas) were operated on by OBS techniques and prospectively followed. Neoadjuvant and adjuvant oncologic treatments were also delivered as indicated. RESULTS: Free margins were obtained in 95% of cancer patients. During the 26 months of follow-up, local recurrence happened in 7 (2.9%) patients, of which 1 underwent oncologic therapies and 6 underwent completion mastectomy. Complications postponed adjuvant therapies in 3 (1.2%) patients. Postsurgically, metastases were diagnosed in 8 (3.3%) patients. Two patients (.8%) died of cancer. CONCLUSIONS: Outcomes of OBS are oncologically acceptable with low frequencies of positive margins and recurrence, while cosmetic results are much improved by OBS.
BACKGROUND: The oncologic efficacy of breast-conserving therapies has been established in recent decades. Oncoplastic breast surgery (OBS), as a leap forward in breast conservation, offers concomitant techniques of oncologic and plastic surgeries that grant better esthetic results. The outcomes of our oncoplastic surgeries from 2007 to 2012 are reported. METHODS: A series of 258 cases with breast masses (18 benign and 240 carcinomas) were operated on by OBS techniques and prospectively followed. Neoadjuvant and adjuvant oncologic treatments were also delivered as indicated. RESULTS: Free margins were obtained in 95% of cancerpatients. During the 26 months of follow-up, local recurrence happened in 7 (2.9%) patients, of which 1 underwent oncologic therapies and 6 underwent completion mastectomy. Complications postponed adjuvant therapies in 3 (1.2%) patients. Postsurgically, metastases were diagnosed in 8 (3.3%) patients. Two patients (.8%) died of cancer. CONCLUSIONS: Outcomes of OBS are oncologically acceptable with low frequencies of positive margins and recurrence, while cosmetic results are much improved by OBS.
Authors: I G Papanikolaou; C Dimitrakakis; F Zagouri; S Marinopoulos; A Giannos; E Zografos; C G Zografos; D Kritikou; A Rodolakis; G C Zografos; D Loutradis Journal: Breast Cancer Date: 2019-04-06 Impact factor: 4.239
Authors: Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff Journal: BJS Open Date: 2021-11-09
Authors: René Aloisio da Costa Vieira; Guilherme Freire Angotti Carrara; Cristovam Scapulatempo Neto; Mariana Andozia Morini; Maria Mitzi Brentani; Maria Aparecida Azevedo Koike Folgueira Journal: Ann Med Surg (Lond) Date: 2016-08-03